BRAIDWELL LP
Q3 2026 Form 13-F

STAMFORD, CONNECTICUT
CIK 0001920938 · CRD 316988 · SEC-registered investment adviser
$2.4B Reported Value Total

BRAIDWELL LP reports 13 total accounts under management (AUM). There are 13 discretionary accounts valued at $3,632,464,658, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
13 funds · $3.6B gross asset value
Hedge Fund: $3.6B · Private Equity Fund: $0
Source: Form ADV filed 2026-09-22
Reported value
$2.4B
Quarter over quarter
+7.3%
Holdings
86
Top-10 concentration
30.7%

Key People

Form ADV owners & control persons
Alexander Thomas Karnal
LIMITED PARTNER
Brian James Kreiter
LIMITED PARTNER
Ken C Joseph
CHIEF COMPLIANCE OFFICER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2026 13F record

Q3 2026 13F filing summary

Q3 2026 Form 13F portfolio summary
Period of report September 30, 2026
Filed November 16, 2026
Form 13F-HR
Reported value $2.4B
Positions 86
Change in reported value -10.9%
New positions 16
Exited positions 14
Position turnover 30.0%
Top-10 concentration 30.7%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 16, 2026
86 $2.4B
Q2 2026 13F
Filed Aug 14, 2026
83 $2.7B
Q1 2026 13F
Filed May 15, 2026
82 $3.0B
Q4 2025 13F
Filed Feb 17, 2026
68 $3.1B
Q3 2025 13F
Filed Nov 14, 2025
64 $3.4B
Q2 2025 13F
Filed Aug 14, 2025
45 $2.9B
Q1 2025 13F
Filed May 15, 2025
52 $2.8B
Q4 2024 13F
Filed Feb 14, 2025
59 $3.4B
Q3 2024 13F
Filed Nov 14, 2024
65 $3.5B
Q2 2024 13F
Filed Aug 14, 2024
58 $3.2B
Q1 2024 13F
Filed May 15, 2024
51 $3.1B
Q4 2023 13F
Filed Feb 14, 2024
47 $2.7B
Q3 2023 13F
Filed Nov 14, 2023
60 $3.2B
Q2 2023 13F
Filed Aug 14, 2023
58 $3.1B
Q1 2023 13F
Filed May 15, 2023
57 $3.0B
Q4 2022 13F
Filed Feb 14, 2023
63 $3.0B

Top 20 holdings · Q3 2026

Largest Q3 2026 13F positions by reported value
# Holding Reported value % of portfolio
1 KOD KODIAK SCIENCES INC $102.9M 4.27%
2 CAI CARIS LIFE SCIENCES INC $84.1M 3.49%
3 EWTX EDGEWISE THERAPEUTICS INC $84.0M 3.49%
4 ATEC ALPHATEC HLDGS INC $74.6M 3.1%
5 IRTC IRHYTHM HOLDINGS INC $72.8M 3.02%
6 ATEC 0.75 03/15/30 ALPHATEC HLDGS INC $69.3M 2.88%
7 HNGE HINGE HEALTH INC $63.7M 2.64%
8 SYRE SPYRE THERAPEUTICS INC $63.6M 2.64%
9 XENE XENON PHARMACEUTICALS INC $63.5M 2.64%
10 NEO NEOGENOMICS INC $61.5M 2.55%
11 GKOS GLAUKOS CORP $56.5M 2.34%
12 VERA VERA THERAPEUTICS INC $55.8M 2.31%
13 TMDX TRANSMEDICS GROUP INC $54.6M 2.27%
14 ISRG INTUITIVE SURGICAL INC $51.2M 2.13%
15 AVAH AVEANNA HEALTHCARE HLDGS INC $48.0M 1.99%
16 NBIX NEUROCRINE BIOSCIENCES INC $47.7M 1.98%
17 DNTH DIANTHUS THERAPEUTICS INC $45.6M 1.89%
18 BTSG BRIGHTSPRING HEALTH SVCS INC $45.5M 1.89%
19 GENB GENERATE BIOMEDICINES INC $44.5M 1.85%
20 MRVI MARAVAI LIFESCIENCES HLDGS I $42.2M 1.75%

Values as reported on the Q3 2026 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings